Cargando…

Efficacy, Safety and Immunogenicity of AVT02 Versus Originator Adalimumab in Subjects with Moderate to Severe Chronic Plaque Psoriasis: A Multicentre, Double-Blind, Randomised, Parallel Group, Active Control, Phase III Study

BACKGROUND: AVT02 (adalimumab) is a proposed biosimilar to Humira(®). AVT02 is produced at a 100 mg/mL concentration with a citrate-free formulation. OBJECTIVES: The aim of this study was to compare the efficacy, safety and immunogenicity of AVT02 versus Humira(®) in subjects with moderate to severe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Feldman, Steven R., Reznichenko, Nataliya, Pulka, Grazyna, Kingo, Külli, George Galdava, Berti, Fausto, Sobierska, Joanna, Dias, Roshan, Guenzi, Eric, Hendrik Otto, Haliduola, Halimu N., Kay, Richard, Stroissnig, Heimo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8520467/ https://www.ncbi.nlm.nih.gov/pubmed/34657274 http://dx.doi.org/10.1007/s40259-021-00502-w

Ejemplares similares

Assessing the Interchangeability of AVT02 and Humira(®) in Participants with Moderate‑to‑Severe Chronic Plaque Psoriasis: Pharmacokinetics, Efficacy, Safety, and Immunogenicity Results from a Multicenter, Double-Blind, Randomized, Parallel-Group Study
por: Feldman, Steven R., et al.
Publicado: (2023)

Joint analysis of PK and immunogenicity outcomes using factorization model − a powerful approach for PK similarity study
por: Haliduola, Halimu N., et al.
Publicado: (2022)

AVT02: An Adalimumab Biosimilar
por: Kang, Connie
Publicado: (2022)

Correction to: AVT02: An Adalimumab Biosimilar
por: Kang, Connie
Publicado: (2022)

Social effects on AVT and CRF systems
por: Backström, Tobias, et al.
Publicado: (2021)

26: AUDITORY-VERBAL THERAPY (AVT) AND EVIDENCE-BASED PRACTICE (EBP)
por: mortazavi, Zahra, et al.
Publicado: (2017)

Polymorphisms in IL36G gene are associated with plaque psoriasis
por: Traks, Tanel, et al.
Publicado: (2019)

In vivo characterization of [(18)F]AVT-011 as a radiotracer for PET imaging of multidrug resistance
por: Kannan, Pavitra, et al.
Publicado: (2019)

AVT: Multicenter aortic vessel tree CTA dataset collection with ground truth segmentation masks
por: Radl, Lukas, et al.
Publicado: (2022)

Synthesis, characterization, and radiosynthesis of fluorine-18-AVT-011 as a Pgp chemoresistance imaging marker
por: Kumar, Pardeep, et al.
Publicado: (2022)

Visual Loss Induced by Adalimumab Used for Plaque Psoriasis
por: Saffra, Norman, et al.
Publicado: (2017)

How does oestradiol influence the AVT/IT system in female round gobies during different reproductive phases?
por: Kalamarz-Kubiak, Hanna, et al.
Publicado: (2017)

Psoriasis and Cardiovascular Risk—Do Promising New Biomarkers Have Clinical Impact?
por: Kaur, Sirje, et al.
Publicado: (2017)

Profiling Blood Serum Extracellular Vesicles in Plaque Psoriasis and Psoriatic Arthritis Patients Reveals Potential Disease Biomarkers
por: Lättekivi, Freddy, et al.
Publicado: (2022)

Real-Life Effectiveness of Adalimumab Biosimilars in Patients with Chronic Plaque Psoriasis
por: Bellinato, Francesco, et al.
Publicado: (2022)

Effects of adalimumab and secukinumab on comorbidities associated with metabolism in patients with plaque psoriasis
por: Zhang, Si, et al.
Publicado: (2022)

Functional Expression and Characterization of Schizosaccharomyces pombe Avt3p as a Vacuolar Amino Acid Exporter in Saccharomyces cerevisiae
por: Chardwiriyapreecha, Soracom, et al.
Publicado: (2015)

How Effective Is Auditory–Verbal Therapy (AVT) for Building Language Development of Children with Cochlear Implants? A Systematic Review
por: Binos, Paris, et al.
Publicado: (2021)

Using Medical History Embedded in Biometrics Medical Card for User Identity Authentication: Data Representation by AVT Hierarchical Data Tree
por: Fong, Simon, et al.
Publicado: (2012)

Eruptive lentiginosis confined to areas of regressing psoriatic plaques after adalimumab treatment()()
por: Garcia-Souto, Fernando
Publicado: (2021)

Effects of secukinumab and adalimumab on serum uric acid level in patients with plaque psoriasis
por: Zhao, Zheng, et al.
Publicado: (2022)

Gastrointestinal safety, chemotherapeutic potential, and classic pharmacological profile of NOSH‐naproxen (AVT‐219) a dual NO‐ and H(2)S‐releasing hybrid
por: Chattopadhyay, Mitali, et al.
Publicado: (2016)

Long-Term Cost-Effectiveness Analysis of Etanercept and Adalimumab for Plaque Psoriasis not Associated with Arthritis
por: Ruano, Juan, et al.
Publicado: (2013)

Comparative efficacy of secukinumab against adalimumab and infliximab in patients with moderate-to-severe plaque psoriasis
por: Pan, Ran, et al.
Publicado: (2022)

Successful Treatment of a Patient with Pyoderma Gangrenosum, Plaque Psoriasis and Palmoplantar Pustulosis with Adalimumab
por: Chu, Yuqi, et al.
Publicado: (2022)

Efficacy of Secukinumab Across Subgroups and Overall Safety in Pediatric Patients with Moderate to Severe Plaque Psoriasis: Week 52 Results from a Phase III Randomized Study
por: Magnolo, Nina, et al.
Publicado: (2022)

Long-term use of adalimumab in the treatment of moderate to severe plaque psoriasis: a review of the literature
por: Moore, Angela Y, et al.
Publicado: (2010)

Identification of an optimal method for extracting RNA from human skin biopsy, using domestic pig as a model system
por: Reimann, Ene, et al.
Publicado: (2019)

The metabolic analysis of psoriasis identifies the associated metabolites while providing computational models for the monitoring of the disease
por: Ottas, Aigar, et al.
Publicado: (2017)

Meta‐Analyses of Clinical Efficacy of Risankizumab and Adalimumab in Chronic Plaque Psoriasis: Supporting Evidence of Risankizumab Superiority
por: Witjes, Han, et al.
Publicado: (2019)

OA03.01. Biomedical studies on the classical ayurvedic treatment of rheumatoid arthritis in AVT, Coimbatore (19762011): After the biomedical auscultation, Ayurveda at a turning point?
por: Olivier, Talpain
Publicado: (2013)

Transcriptional landscape of psoriasis identifies the involvement of IL36 and IL36RN
por: Keermann, Maris, et al.
Publicado: (2015)

Methotrexate and Adalimumab Decrease the Serum Levels of Cardiovascular Disease Biomarkers (VCAM-1 and E-Selectin) in Plaque Psoriasis
por: Zdanowska, Natalia, et al.
Publicado: (2020)

Matching-Adjusted Indirect Comparison of the Long-Term Efficacy of Deucravacitinib Versus Adalimumab for Moderate to Severe Plaque Psoriasis
por: Armstrong, April W., et al.
Publicado: (2023)

Demonstration of Physicochemical and Functional Similarity of Biosimilar Adalimumab-aqvh to Adalimumab
por: Jiang, Yijia, et al.
Publicado: (2023)

Adalimumab improves health-related quality of life in patients with moderate to severe plaque psoriasis compared with the United States general population norms: Results from a randomized, controlled Phase III study
por: Revicki, Dennis A, et al.
Publicado: (2008)

Correction to: Matching-Adjusted Indirect Comparison of the Long-Term Efficacy of Deucravacitinib Versus Adalimumab for Moderate to Severe Plaque Psoriasis
por: Armstrong, April W., et al.
Publicado: (2023)

Changes in Lipoprotein Particles in the Blood Serum of Patients with Lichen Planus
por: Ilves, Liis, et al.
Publicado: (2023)

Adalimumab and anti-adalimumab LISA-TRACKER immunoassays performance criteria for therapeutic drug monitoring of adalimumab-amgen biosimilar (ABP501)
por: Francois, Fabien, et al.
Publicado: (2021)

Long-Term Psoriasis Control with Guselkumab, Adalimumab, Secukinumab, or Ixekizumab in the USA
por: Fitzgerald, Timothy, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_flee5t0ajnm9c89vq169qru908